MCM2 and Alzheimer disease: In this study, the effect of RP11-59J16.2/MCM2 on the development of AD would be investigated to explore the molecular mechanism of the novel lncRNA RP11-59J16.2 on regulation of Aβ-induced neuronal damage in the AD cell model by targeting MCM2, and to provide a potential target and theoretical basis for the treatment of AD.